Add Yahoo as a preferred source to see more of our stories on Google. FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods ...

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...

A drug’s therapeutic index is a ratio that doctors use when prescribing medications and determining dosage. It shows how much of a drug a person’s blood can contain before it becomes toxic. The ...

The evaluation of drug safety in clinical trials is a critical element of the drug development process, ensuring that therapeutic benefits outweigh potential harms. Clinical trials, particularly in ...

The U.S. Food and Drug Administration has released a proposal on how it plans to handle safety issues related to marketed drugs. Significant safety issues related to post-market drugs include serious ...

For decades in life sciences, pharmacovigilance (PV)—a critical reinforcer of drug safety—has been a reactive function. Its remit has been to collect details of adverse events (side-effects of ...

The addition later this year of oral-fluid drug testing for marijuana, which typically detects use only for up to 72 hours after use, could allow truck drivers to use the drug and avoid detection, ...

Prescription and over-the-counter (OTC) medications play vital roles in treating health conditions for older adults, helping ease symptoms and supporting overall well-being. To ensure the intended ...

A truck driver who failed a cocaine test exploited regulatory gaps to pose as a Substance Abuse Professional, clearing over 1,000 drug violations in the FMCSA Clearinghouse. The fraud exposed ...

Results from a new trial published in The Lancet Global Health show that a mobile application, Med Safety, improved the reporting of suspected adverse drug reactions (ADRs) by health care workers in ...

India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.